Projects per year
Bone and mineral diseases encompass a variety of conditions that involve altered skeletal homeostasis and are frequently associated with changes in circulating calcium, phosphate, or vitamin D metabolites. These disorders often have a genetic etiology and comprise monogenic disorders caused by a single-gene mutation, which may be germline or somatic, or an oligogenic or polygenic condition involving multiple genetic variants. Single-gene mutations causing Mendelian diseases are usually highly penetrant, whereas the gene variants contributing to oligogenic or polygenic disorders are each associated with smaller effects with additional contributions from environmental factors. The detection of monogenic disorders is clinically important and facilitates timely assessment and management of the patient and their affected relatives. The diagnosis of monogenic metabolic bone disorders requires detailed clinical assessment of the wide variety of symptoms and signs associated with these diseases. Thus, clinicians should undertake a systematic approach commencing with careful history taking and physical examination, followed by appropriate laboratory and skeletal imaging investigations. Finally, clinicians should be familiar with the range of molecular genetic tests available to ensure their appropriate use and interpretation. These considerations are reviewed in this chapter.
|Title of host publication||Bone Regulators and Osteoporosis Therapy|
|Editors||Paula H. Stern|
|Place of Publication||Switzerland|
|Number of pages||27|
|Publication status||Published - 2020|
|Name||Handbook of Experimental Pharmacology|
- Next-generation sequencing
ASJC Scopus subject areas
- Pharmacology, Toxicology and Pharmaceutics(all)
FingerprintDive into the research topics of 'Genetics of Skeletal Disorders'. Together they form a unique fingerprint.
- 1 Finished